ARR-002

N/A

Report date: 2026/04/10 20:01:49
First In Class

Base Information

Drug NameARR-002
Drug Alias NameARR-002
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-Mucin-16Anti-Sodium-dependent phosphate transport protein 2B
TargetsMucin-16Sodium-dependent phosphate transport protein 2B
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAarvik Therapeutics IncArriVent Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAarvik Therapeutics IncArriVent Biopharma Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A